Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

Interobserver and intraobserver variability using the Fuhrman grading system for renal cell carcinoma.

Al-Aynati M, Chen V, Salama S, Shuhaibar H, Treleaven D, Vincic L.

Arch Pathol Lab Med. 2003 May;127(5):593-6.

PMID:
12708904
[PubMed - indexed for MEDLINE]
2.

Intraobserver and interobserver variability of Fuhrman and modified Fuhrman grading systems for conventional renal cell carcinoma.

Bektas S, Bahadir B, Kandemir NO, Barut F, Gul AE, Ozdamar SO.

Kaohsiung J Med Sci. 2009 Nov;25(11):596-600. doi: 10.1016/S1607-551X(09)70562-5.

PMID:
19858038
[PubMed - indexed for MEDLINE]
3.

Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: Assessment of 241 patients with > 15-year follow-up.

Lang H, Lindner V, de Fromont M, Molinié V, Letourneux H, Meyer N, Martin M, Jacqmin D.

Cancer. 2005 Feb 1;103(3):625-9.

PMID:
15611969
[PubMed - indexed for MEDLINE]
Free Article
4.

Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma.

Ficarra V, Martignoni G, Maffei N, Brunelli M, Novara G, Zanolla L, Pea M, Artibani W.

Cancer. 2005 Jan 1;103(1):68-75.

PMID:
15573369
[PubMed - indexed for MEDLINE]
Free Article
5.

Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma.

Serrano MF, Katz M, Yan Y, Kibel AS, Humphrey PA.

Cancer. 2008 Aug 1;113(3):477-83. doi: 10.1002/cncr.23574.

PMID:
18484589
[PubMed - indexed for MEDLINE]
Free Article
6.

The chromophobe tumor grading system is the preferred grading scheme for chromophobe renal cell carcinoma.

Finley DS, Shuch B, Said JW, Galliano G, Jeffries RA, Afifi AA, Castor B, Magyar C, Sadaat A, Kabbinavar FF, Belldegrun AS, Pantuck AJ.

J Urol. 2011 Dec;186(6):2168-74. doi: 10.1016/j.juro.2011.07.068. Epub 2011 Oct 19.

PMID:
22014797
[PubMed - indexed for MEDLINE]
7.

The use of simplified versions of the Fuhrman nuclear grading system in clinical practice requires the agreement of a multidisciplinary panel of experts.

Ficarra V, Novara G, Martignoni G.

Eur Urol. 2009 Nov;56(5):782-4; discussion 784-5. doi: 10.1016/j.eururo.2009.07.024. Epub 2009 Jul 28. No abstract available.

PMID:
19660853
[PubMed - indexed for MEDLINE]
8.

Application of simplified Fuhrman grading system in clear-cell renal cell carcinoma.

Hong SK, Jeong CW, Park JH, Kim HS, Kwak C, Choe G, Kim HH, Lee SE.

BJU Int. 2011 Feb;107(3):409-15. doi: 10.1111/j.1464-410X.2010.09561.x. Epub 2010 Aug 26.

PMID:
20804473
[PubMed - indexed for MEDLINE]
9.

A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinoma.

Sun M, Lughezzani G, Jeldres C, Isbarn H, Shariat SF, Arjane P, Widmer H, Pharand D, Latour M, Perrotte P, Patard JJ, Karakiewicz PI.

Eur Urol. 2009 Nov;56(5):775-81. doi: 10.1016/j.eururo.2009.06.008. Epub 2009 Jun 21.

PMID:
19573980
[PubMed - indexed for MEDLINE]
10.

Advances and controversies in grading and staging of renal cell carcinoma.

Delahunt B.

Mod Pathol. 2009 Jun;22 Suppl 2:S24-36. doi: 10.1038/modpathol.2008.183. Review.

PMID:
19494851
[PubMed - indexed for MEDLINE]
Free Article
11.

Morphometric index of adult renal cell carcinoma. Comparison with the Fuhrman grading system.

Montironi R, Santinelli A, Pomante R, Mazzucchelli R, Colanzi P, Filho AL, Scarpelli M.

Virchows Arch. 2000 Jul;437(1):82-9.

PMID:
10963384
[PubMed - indexed for MEDLINE]
12.

Fine needle aspiration biopsy of renal cell carcinoma. Cytologic parameters and their concordance with histology and flow cytometric data.

Cajulis RS, Katz RL, Dekmezian R, el-Naggar A, Ro JY.

Acta Cytol. 1993 May-Jun;37(3):367-72.

PMID:
8498138
[PubMed - indexed for MEDLINE]
13.

Interobserver reproducibility of a grading system for chromophobe renal cell carcinoma.

Pérez-Pedrosa A, Ortiz-Rey JA, Lorenzo-Mahía Y, Iglesias-Rodríguez B, Peteiro-Cancelo A, González-Carreró J.

Actas Urol Esp. 2013 Jun;37(6):338-41. doi: 10.1016/j.acuro.2012.04.005. Epub 2012 Oct 8. English, Spanish.

PMID:
23058995
[PubMed - indexed for MEDLINE]
14.

Grading of renal cell carcinoma.

Goldstein NS.

Urol Clin North Am. 1999 Aug;26(3):637-42, vii. Review.

PMID:
10494294
[PubMed - indexed for MEDLINE]
15.

Fuhrman grading is not appropriate for chromophobe renal cell carcinoma.

Delahunt B, Sika-Paotonu D, Bethwaite PB, McCredie MR, Martignoni G, Eble JN, Jordan TW.

Am J Surg Pathol. 2007 Jun;31(6):957-60.

PMID:
17527087
[PubMed - indexed for MEDLINE]
16.

Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype.

Delahunt B, Bethwaite PB, Nacey JN.

Pathology. 2007 Oct;39(5):459-65. Review.

PMID:
17886093
[PubMed - indexed for MEDLINE]
17.

Grading systems in renal cell carcinoma.

Novara G, Martignoni G, Artibani W, Ficarra V.

J Urol. 2007 Feb;177(2):430-6. Review.

PMID:
17222604
[PubMed - indexed for MEDLINE]
18.

Prognostic ability of simplified nuclear grading of renal cell carcinoma.

Rioux-Leclercq N, Karakiewicz PI, Trinh QD, Ficarra V, Cindolo L, de la Taille A, Tostain J, Zigeuner R, Mejean A, Patard JJ.

Cancer. 2007 Mar 1;109(5):868-74.

PMID:
17262800
[PubMed - indexed for MEDLINE]
Free Article
19.

[Epidemiology, novelty in the classification of renal cancer].

Iurin AG.

Arkh Patol. 2007 Jan-Feb;69(1):49-54. Review. Russian.

PMID:
19385136
[PubMed - indexed for MEDLINE]
20.

Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.

Gudbjartsson T, Hardarson S, Petursdottir V, Thoroddsen A, Magnusson J, Einarsson GV.

Eur Urol. 2005 Oct;48(4):593-600.

PMID:
15964127
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk